Useful links

Link	Useful for
International Society on Thrombosis and Haemostasis (ISTH)	Thrombosis and haemostasis; research; clinical trials outcomes; education.
Thrombosis and Haemostasis Society of Australia and New Zealand (THANZ)	Australia and New Zealand society for information on thrombosis and haemostasis.
Asian-Pacific Society on Thrombosis and Haemostatis (APSTH)	Thrombosis and haemostasis research in the Asian Pacific region.
Australian Haemophilia Centre Directors' Organisation (AHCDO)	Haemophilia - AHCDO is the national medical body for haemophilia in Australia.
Murdoch University	Research based tertiary institute degrees.
Clinicaltrials.gov	ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world.
Cancer Council Western Australia	Specific focus on clinical trials offered within Western Australia.
ClinTrialRefer	App for connecting doctors, patients and clinical trial sites.
Australia New Zealand Clinical Trials Registry (ANZ CTR)	The ANZCTR is an online registry of clinical trials being undertaken in Australia, New Zealand and elsewhere.

Latest

Feedback
User Feedback
End of Financial Year Appeal

Your End of Financial Year gift will allow our scientists to continue to develop world-class research into blood disorders and enable our clinical trials unit to continue to grow.
Elie's Story

When Elie was a young, fit and healthy 22-year-old he noticed a lump in the side of his neck. He went to his GP complaining of fatigue, insomnia, and severe itching. After being misdiagnosed with glandular fever and then a mystery virus, he received a call from his doctor.

Accessibility
COVID-19 and Thrombosis

The International Society of Thrombosis and Haemostasis has released information on COVID-19 and thrombosis. Here are the important facts; Having a blood clot does not increase your risk of acquiring COVID-19. Taking anticoagulants (blood-thinning medication) for a blood clot disorder also does not increase your risk of acquiring COVID-19.
End of Financial Year Appeal

Your End of Financial Year gift will allow our scientists to continue to develop world-class research into blood disorders and enable our clinical trials unit to continue to grow.
Privacy Policy

THE PERTH BLOOD INSTITUTE LIMITED ABN: 24164941815 (trading as Perth Blood Institute) takes your privacy seriously. We respect and uphold your right to privacy protection under the Australian Privacy Principles (APPs), by regulating the way in which we collect, use, disclose, hold and destroy your personal information. This Privacy Policy covers all personal information held by us.
COVID-19 - Impact on blood transfusions and blood donations

Some members of the community may be concerned about the potential transmission of the COVID-19 virus through blood products, such as through blood transfusions. If you rely on blood products, you should feel confident to continue to receive them.
Research Team Awarded DARF Dementia Grant

Perth Blood Institute is pleased to announce it is the recipient of the Norma Beaconsfield Project Grant, awarded by the Dementia Australia Research Foundation (DARF). This grant will allow the Platelet Research Team to continue important investigations into the effect of blood-thinning medication on dementia risk.
Multiple Myeloma Clinical Trials Appeal

PBI is committed to developing new treatments for blood cancers and facilitates patient participation in clinical trials to access potentially lifesaving treatments not currently available elsewhere. Your support will enable us to participate in testing new treatment options to improve the health outcomes for patients with blood disorders, including multiple myeloma.
Elie's Story

When Elie was a young, fit and healthy 22-year-old he noticed a lump in the side of his neck. He went to his GP complaining of fatigue, insomnia, and severe itching. After being misdiagnosed with glandular fever and then a mystery virus, he received a call from his doctor.
Understanding platelet dysfunction in Chronic Lymphocytic Leukemia

This project aims to examine platelets from healthy and Chronic Lymphocytic Leukemia (CLL) individuals to better understand the mechanisms underpinning platelet dysfunction in CLL, which may lead to better anti-cancer treatment strategies.
Perth Blood Institute

Your donation can help PBI to fund vital translational research into blood disorders including thrombosis and haemophilia; support a clinical research investigation into the development of a new treatment or intervention; or help us develop educational programs to foster the next generation of career haematologists.

Perth Blood Institute

Your donation can help PBI to fund vital translational research into blood disorders including thrombosis and haemophilia; support a clinical research investigation into the development of a new treatment or intervention; or help us develop educational programs to foster the next generation of career haematologists. Read more

Donate Fundraise

Link

Useful for